AI assistant
Sending…
Acumen Pharmaceuticals, Inc. — Director's Dealing 2021
Jul 1, 2021
34208_dirs_2021-06-30_9026635a-f5ec-448e-815e-16746d978d20.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Acumen Pharmaceuticals, Inc. (ABOS)
CIK: 0001576885
Period of Report: 2021-06-30
Reporting Person: Fountain Nathan B (Director)
More from Acumen Pharmaceuticals, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 26
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Jan 28
Director's Dealing
2026
Jan 23
Director's Dealing
2026
Jan 23
Director's Dealing
2026
Jan 23